Attitudes towards COVID-19 vaccination in patients with inflammatory bowel disease.
Tuan A Duong, Robert V Bryant, Jane M Andrews, Kate D Lynch
Author Information
Tuan A Duong: Inflammatory Bowel Disease Service, Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia. ORCID
Robert V Bryant: Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
Jane M Andrews: Inflammatory Bowel Disease Service, Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia.
Kate D Lynch: Inflammatory Bowel Disease Service, Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia. ORCID
The majority of the Australian public are willing to have a Coronavirus disease 2019 (COVID-19) vaccination. It is unclear whether people with inflammatory bowel disease (IBD) have the same attitude towards COVID-19 vaccination. A survey was performed to assess the attitude of patients with IBD towards COVID-19 vaccination in South Australia. Two-thirds of surveyed patients with IBD were willing to accept COVID-19 vaccine. Females and younger patients were less likely to accept the COVID-19 vaccine, as were those who had never had a discussion around vaccines.
